Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer

Description

Recorded live: August 9, 2022
Click here to view supporting publication

Presenter:
Vicky Makker, MD
USA

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Multidisciplinary Approach to Treating Advanced Endometrial Cancer

FREE

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

FREE

Emerging data in platinum resistance advanced ovarian cancer

FREE

IGCS 2024 Ovarian Master Sessions: The Era of Targeted Therapies

FREE

Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial

FREE

Uterine Cancers in the Molecular Era: Changing Trends and Implications

FREE

Patient reported outcomes exploring quality of life in PROC and novel therapeutics: mirvetuximab in recurrent ovarian cancer

FREE

IGCS 2024 Endometrial Cancer Master Session

FREE

Journal Club - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA

FREE